Connect with us

Medical Research

CBD as an Alternative Steroid: Is Cannabidiol a Viable Option to Use?

Published

on

CBD as an Alternative Steroid: Is Cannabidiol a Viable Option to Use?
  • STERO Biotechs has been researching the potential for CBD-based remedies for inflammatory and autoimmune diseases.
  • Steroids can be highly addictive over time.

Steroids are a common way to treat 100+ diseases related to chronic inflammatory and autoimmune diseases. However, the founders of Talent Biotechs have taken a chance on the exit of a cannabis-based drug company, introducing their new startup called STERO Biotechs. With millions of people have been on high doses or longtime use of steroids, the side effects can’t be ignored.

Biotech treatment options may be helpful for many of these circumstances, but the high price makes these options less attractive, and STERO Biotech CBD wants to help. Dr. Sari Prutchi Sagiv, the CSO of STERO Biotechs, stated.

“It’s no coincidence that we at STERO Biotechs have discovered that besides other positive effects, administering CBD allows us to reduce patients’ steroid doses and in some cases, eliminate their use of increase their effectiveness.”

Israel is a leader in the research of cannabis, and researchers in this country were responsible for isolating THC in marijuana. However, the progress has evolved substantially since then, and the Israel Ministry of Health has been working to establish regulation amongst the 22 clinical trials that have that are going on.

STERO Biotechs Ltd. was originally founded in 2017 with a headquarters in Israel. The company is committed to researching and developing drugs with CBD in an effort to offer steroid-sparing therapy that could help millions of patients. The majority of the therapies could help with inflammatory and autoimmune diseases, but without the addictive nature of steroids.

The company that exited the industry was Talent Biotechs, and former leaders David Bassa, Dr. Moshe Yeshurun, and Dr. Sari Prutchi Sagiv all founded STERO Biotechs together. Talent Biotechs was one of the few companies that have been working on cannabis-based, FDA-oriented clinical trials for drug development since 2011. The preliminary results from STERO Biotech stem from the findings of the founders while still at Talent.

Cheryl Anne hails from Great Britain and casts a large shadow with her master’s degree in Relationship Therapy as well as a number of other professional accreditations. While she specializes in psychological thrillers and self-help books, her undeniable and uncanny knack for sifting through the cracks of the cannabis and CBD space are extremely necessary and sought after.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.